​​

​​​ On this page

About the NSW Pharmacy Trial

The NSW Pharmacy Trial allows appropriately trained pharmacists to manage common skin conditions. As part of this trial they can provide some medications usually only available with a prescription.

The trial is run by the University of Newcastle in association with the University of Technology Sydney, University of New England, Charles Sturt University, The George Institute for Global Health and the Hunter Medical Research Institute, peak bodies and other professional organisations.

The trial will ensure patient safety is promoted while allowing for robust data to be gathered. The findings from this trial will inform the role of pharmacists and pharmacies in our healthcare system.

As part of the NSW Pharmacy trial, participating pharmacists:

  • can help manage minor skin conditions for eligible patients, including herpes zoster (shingles), impetigo (school sores), atopic dermatitis (eczema) and mild plaque psoriasis – from 19 July 2024 until February 2025 or as soon as the maximum number of trial-supported consultations has been reached.
  • were able to help manage uncomplicated urinary tract infections (UTIs) for eligible women aged from 18 to 65 years (inclusive) – closed as of 31 May 2024. Pharmacists can now provide UTI management services as part of their usual practice. Visit Treatment of UTIs - information for pharmacists​.

Eligible patients

As part of the trial, specific eligibility criteria are in place to ensure patients receive appropriate care.

Pharmacists must refer to clinical management guidelines or protocols when assessing a person's eligibility, assessment and overall management, which may include referral to a GP or an Emergency Department. 

​Skin conditions

Management of skin conditions can only be offered to patients with symptoms of:

  • mild to moderate atopic dermatitis (eczema) and are aged between 6 months and 65 years old (inclusive)​
  • herpes zoster (shingles) and are 18 years and older
  • impetigo (school sores) and are 12 months and older
  • mild plaque psoriasis and are 18 years and older.

The research team will provide additional guidance around inclusion criteria for participation in the trials. Please refer to the NSW Health Authority​, which provides information on what is considered an 'approved pharmacy' and an 'approved pharmacist'.

If you are a pharmacist or pharmacy owner who has not participated in earlier stages of the NSW Government Pharmacy Trial but are interested in joining the dermatology trial, please contact the University of Newcastle at NSWPharmacyTrial@newcastle.edu.au​

A limited number of additional pharmacies may be able to join the trial. The University of Newcastle team will guide you on eligibility requirements.

Mandatory training

To ensure safe clinical care and familiarity with the specific requirements of the trial, all participating pharmacists must complete mandatory training before providing any services.

The research team will provide you with guidance on training requirements once your participation is confirmed.

Authority to supply specified restricted substances

Participating pharmacists providing ​​services related to minor skin conditions must comply with the Authority allowing pharmacists to supply medications (dermatology).

This Authority only applies to pharmacists w​ho are participating in the trial.

More information

For questions specifically relating to the research trial, please refer to the FAQ document on the  NSW Health website or email NSWPharmacyTrial@newcastle.edu.au.

Each phase of the NSW Pharmacy Trial is registered with the Australian and New Zealand Clinical Trials Registry (ANZCTR).


Current as at: Saturday 28 September 2024
Contact page owner: Pharmaceutical Services